Ocular Anti-Hypertensives (Glaucoma Drugs) PDF
Document Details
Uploaded by Deleted User
Tags
Summary
This document provides an overview of ocular anti-hypertensives, commonly used to treat glaucoma. It details the underlying mechanisms of glaucoma, risk factors, and pharmacological treatment strategies. The information is presented in an organized manner, encompassing various aspects of glaucoma management.
Full Transcript
Glaucoma: an optic neuropathy initially provoked by multifactorial primary mechanisms of damage (PMOD) characterized by optic nerve head atrophy and secondary induced programmed retinal ganglion cell death causing a characteristic pattern of VF loss Evidence-based supported Primary Mechanisms Of...
Glaucoma: an optic neuropathy initially provoked by multifactorial primary mechanisms of damage (PMOD) characterized by optic nerve head atrophy and secondary induced programmed retinal ganglion cell death causing a characteristic pattern of VF loss Evidence-based supported Primary Mechanisms Of Disease ○ Elevated IOP: Causes Resistance to trabecular aqueous outflow (TO)- collagenous structure 80% out of trabecular meshwork ○ Most posterior ciliary body and then scleral spur Pathophysiology of resistance to TO: ○ Increased herniation TM cytoskeleton ○ Decreased inflammatory signaling to Endothelial Cells Schlemm Canal ○ Increased episcleral VP Any fluid produced that is not blood, has to enter circulation; what only enters veins? Increased pressure in vein Resistance to uveoscleral aqueous outflow (USO) 20% outflow Pathophysiology of resistance to USO: ○ Animal study- longstanding treatment on cynomolgus monkeys w/ a prostaglandin agonists increased spaces b/w CM fibers Too much collagen b/w fibers -> water exiting interrupted -> fluid held back -> increased IOP ○ Decreased ocular blood flow: impacts deterioration of ONH due to GLC Vascular Concept of OBF Look at scribes notes ^ Factors Involved in DOBF What about ocular biomechanical properties? Barriers that limit eye size ○ Weak barrier: IOP too much for intraocular structures b/c can’t hold pressure properly Cornea most important barrier in glaucoma ○ Has resistance Basically ocular pressure might be too high for ocular structures Biomechanical concept Corneal hysteresis (CH): Viscoelasticity Corneal resistant factor (CRF): relates to the overall ocular structural rigidity Central corneal thickness (CCT): extrapolated measurement to imply corneal rigidity; viewed as a protective factor ○ Those who have thin corneas have a higher risk of glaucoma and low CH Factors involved in altered OBMP Properties Secondary mechanism of damage concept Mechanical damage/ischemic insult Glutamate excitotoxicity (diminish glutamate transporter function) ○ Glutamate is a neurotransmitter that maintains the health of nerve fiber layer and maintains homeostasis flow of ions into nerve fiver for maintenance of NMDA receptor NMDA receptor activation (excitement) ○ If you have excess glutamate (damages the nerve), receptor stays open and you can get excess (toxic levels) of Ca Increases Ca+ influx Delayed calcium deregulation Nitric oxide synthesis Neurotrophin depravation Apoptosis Glaucoma risk factors Elevated IOP Suspicious optic disc Family history Race (POAG- Hispanics and blacks) Increasing age Myopia Diabetes mellitus Systemic vascular disease Central retinal vein occlusion Goals for pharmacological medical therapy Reduction in mean IOP to